On the public citation graph
Identification of potential neuroprotective compound from Ganoderma lucidum extract targeting microtubule affinity regulation kinase 4 involved in Alzheimer's disease through molecular dynamics simulation and MMGBSA
0 signed · 40 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/agm2.12217openalex-snapshot
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
inferredcites →https://doi.org/10.1002/agm2.12232openalex-snapshot
Identification of potential neuroprotective compound from Ganoderma lucidum extract targeting microtubule affinity regulation kinase 4 involved in Alzheimer's disease through molecular dynamics simulation and MMGBSA
inferredcites →https://doi.org/10.1007/978-981-13-0347-0_13openalex-snapshot
Pharmacokinetic and Molecular Docking Studies of Plant-Derived Natural Compounds to Exploring Potential Anti-Alzheimer Activity
inferredcites →https://doi.org/10.1007/s11064-021-03303-3openalex-snapshot
Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor
inferredcites →https://doi.org/10.1016/j.tibs.2019.06.004openalex-snapshot
Bringing Molecular Dynamics Simulation Data into View
inferredcites →https://doi.org/10.1021/acs.jafc.1c06304openalex-snapshot
Ganoderic Acid A To Alleviate Neuroinflammation of Alzheimer’s Disease in Mice by Regulating the Imbalance of the Th17/Tregs Axis
inferredcites →https://doi.org/10.1021/ct900587bopenalex-snapshot
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
inferredcites →https://doi.org/10.1039/c8md00472bopenalex-snapshot
ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness
inferredcites →https://doi.org/10.1111/cbdd.12068openalex-snapshot
Structure‐Based Design and Synthesis of Benzothiazole Phosphonate Analogues with Inhibitors of Human ABAD‐Aβ for Treatment of Alzheimer’s Disease
inferredcites →https://doi.org/10.1124/pr.112.007336openalex-snapshot
Computational Methods in Drug Discovery
inferredcites →https://doi.org/10.1155/2020/9894037openalex-snapshot
Ganoderma lucidum Triterpenoids (GLTs) Reduce Neuronal Apoptosis via Inhibition of ROCK Signal Pathway in APP/PS1 Transgenic Alzheimer’s Disease Mice
inferredcites →https://doi.org/10.1186/1423-0127-18-8openalex-snapshot
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
inferredcites →https://doi.org/10.1186/s13024-018-0299-8openalex-snapshot
Advances in developing novel therapeutic strategies for Alzheimer’s disease
inferredcites →https://doi.org/10.1517/14728214.2012.672559openalex-snapshot
Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD)
inferredcites →https://doi.org/10.1517/17460441.2015.1032936openalex-snapshot
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
inferredcites →https://doi.org/10.15252/emmm.202114781openalex-snapshot
Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?
inferredcites →https://doi.org/10.16966/2578-9589.113openalex-snapshot
Molecular Docking, Drug-likeness Studies and ADMET Prediction of Quinoline Imines for Antimalarial Activity
inferredcites →https://doi.org/10.2174/1570159x15666170823095628openalex-snapshot
In Silico Studies in Drug Research Against Neurodegenerative Diseases
inferredcites →https://doi.org/10.2174/157340911795677602openalex-snapshot
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
inferredcites →https://doi.org/10.3346/jkms.2014.29.7.893openalex-snapshot
Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
inferredcites →https://doi.org/10.3389/fphar.2019.00272openalex-snapshot
Alcohol Extracts From Ganoderma lucidum Delay the Progress of Alzheimer’s Disease by Regulating DNA Methylation in Rodents
inferredcites →https://doi.org/10.3389/fphar.2020.00261openalex-snapshot
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
inferredcites →https://doi.org/10.3390/ijms21093272openalex-snapshot
Combination Drug Therapy for the Management of Alzheimer’s Disease
inferredcites →https://doi.org/10.3390/ijms22115559openalex-snapshot
Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl
inferredcites →https://doi.org/10.3390/life11020077openalex-snapshot
Identification of Lead Compounds against Scm (fms10) in Enterococcus faecium Using Computer Aided Drug Designing
inferredcites →https://doi.org/10.3390/molecules200713384openalex-snapshot
Molecular Docking and Structure-Based Drug Design Strategies
inferredcites →https://doi.org/10.5772/intechopen.85096openalex-snapshot
Future Treatment of Alzheimer Disease
inferredcites →https://doi.org/10.5772/intechopen.86174openalex-snapshot
ADME Profiling in Drug Discovery and a New Path Paved on Silica
inferredcites →https://doi.org/10.7150/jbm.26783openalex-snapshot
Current Therapeutic Targets for Alzheimer's Disease
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4774995openalex-extracted
Network Analysis and Computer-Aided Drug Design Targeting the Acetyl Cholinesterase Pathway in Alzheimer's Disease: Unlocking Novel Therapeutic Strategies
inferred← citeshttps://doi.org/10.1007/978-981-95-2774-8_5openalex-snapshot
Molecular Basis and Potential Antioxidant Mechanisms of Medicinal Mushrooms
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116222openalex-snapshot
Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0301179openalex-snapshot
Exploring the most promising anti ‐ Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer’s Disease through molecular docking and molecular dynamics simulation
inferred← citeshttps://doi.org/10.1615/intjmedmushrooms.2023051918openalex-snapshot
Ganoderic Acid A: A Potential Natural Neuroprotective Agent for Neurological Disorders: A Review
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2879310/v1openalex-snapshot
Ebelin lactone as the most promising neuroprotective compound from Bacopa monnieri extract targeting microtubule affinity regulation kinase-4 involved in Alzheimer’s disease: A Computational Study
inferred← citeshttps://doi.org/10.2174/0115672050358397250126151707openalex-snapshot
Tauopathy in AD: Therapeutic Potential of MARK-4
inferred← citeshttps://doi.org/10.2174/0122113525306071240613043139openalex-snapshot
In silico Screening of Plectranthus amboinicus and Hyptis suaveolens Phytochemicals: Novel Repellents Targeting Odorant Binding Proteins of Aedes aegypti and Aedes albopictus
inferred← citeshttps://doi.org/10.31083/j.fbl2904142openalex-snapshot
Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
inferred← citeshttps://doi.org/10.3390/molecules29112516openalex-snapshot
The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks
showing the first 10 of 11 · page through all 11
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.